Clinical Trial Update: Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol (P04408/MK-4031-261)

View source ↗

Summary

Post-marketing surveillance study of ex-intravenous drug abusers with chronic hepatitis C treated with PegIntron plus Rebetol; results were completed and posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)
• Rebetol (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic, Substance Abuse, Intravenous | Status: COMPLETED | Results posted: 2010-05-17